Choose the best clinical strategy with the help of our seasoned clinical drug development experts.…
You are a biotech scouting for the right partner to support your clinical development ?
Emerging biotech companies with promising molecules have the potential to bring game-changing compounds to market, but they need strategic partners who can make the most of their available resources and planned investments.
WE PROVIDE ALL THE RESOURCES AND INFRASTRUCTURE
NEEDED TO BRING INNOVATIVE MOLECULES TO MARKET
Over the past four decades, ICTA has successfully supported biotech companies. Our clients recognise our customer-oriented culture, driven by a multidisciplinary team with an innovative spirit, and find value in :
- our strong methodological skills to adapt to the diversity of product types and innovative projects encountered in the biotechnology landscape
- our intellectual flexibility combined with our operational experience to identify and anticipate the often unprecedented problems posed by innovative biotechnology projects to provide tailored solutions.
- our ability to adapt to complex situations and redefine specifications often poorly defined at the outset of the project
- our capacity to advise on a development strategy from a methodological and statistical point of view to optimise and secure the future of your project. In particular, we can help you in positioning your product in terms of therapeutic area, choice and number of indications to be developed as a priority
- our experience and expertise in regulatory methodology to determine the regulatory steps to be taken in order to have sufficient information without locking in options
- our proven experience across an extensive range of therapeutics including novel therapies such as cell and gene therapies, first-in-class immunotherapies and others
- our transparent and effective communication. Our dedicated project managers, single points of contact, define communication plans that reflect clarity of expectations and objectives, allocation of roles and responsibilities, and channels for proactive communications and issue escalation
ICTA HALLMARKS: THE RESPONSIVENESS AND PROXIMITY OF A HUMAN-SIZED CRO WITH THE ORGANISATION AND EXPERTISE OF A LARGE CRO
Building on a wealth of experience and specialised expertise, ICTA offers a full-service solution to help clients implement smartly designed, cost-effective and timely product development programs – while also taking into account the practical considerations of translating a plan into action.
By choosing a mid-sized CRO like ICTA, you access the best combination of large and small companies:
responsiveness, personalised relationships, and an international infrastructure to facilitate your success, no matter how complex your drug development programme is.